Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing's disease

Shrikrishna V Acharya1, Raju A Gopal, Anurag Lila

  • 1Department of Endocrinology, Seth G S Medical College and KEM Hospital, Mumbai 400 012, Maharashtra, India. drshri25@rediffmail.com

Pituitary
|August 7, 2010
PubMed

Insights

Most children with Cushing's disease (CD) experience delayed skeletal maturation, impacting final height. Early diagnosis is crucial for improving growth outcomes in pediatric patients with CD.

Area of Science:

  • Pediatric Endocrinology
  • Skeletal Development

Background:

  • Pediatric Cushing's disease (CD) often leads to growth retardation.
  • Limited data exists on skeletal maturation at diagnosis for pediatric CD.

Purpose of the Study:

  • To analyze factors influencing skeletal maturation and final height in Asian Indian pediatric CD patients.
  • To investigate the relationship between bone age delay and clinical/biochemical variables.

Main Methods:

  • Retrospective analysis of 48 pediatric CD patients (mean age 14.84 years).
  • Bone age (BA) determined using the Greulich Pyle method.
  • Comparison of BA delay with chronological age (CA), height SDS, and biochemical markers.

Main Results:

  • 73% of patients (35/48) exhibited delayed bone age (mean delay 1.6 years).
  • BA delay negatively correlated with height SDS (r = -0.594) and positively with CA (r = 0.247).
  • No significant correlation found between BA delay and symptom duration, cortisol levels, ACTH, or LDDST results.

Conclusions:

  • Delayed bone age is common in pediatric Cushing's disease and correlates with height SDS at diagnosis.
  • Early diagnosis of CD may mitigate skeletal maturation delay, potentially improving final height outcomes.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...